Inventor

HASLANGER MARTIN F

US52 patents

⚠️ This page may combine multiple inventors who share the name “HASLANGER MARTIN F”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HASLANGER MARTIN F

SQUIBB & SONS INC

Hydroxamates

7-Oxabicycloheptane substituted thio prostaglandin analogs and their use in the treatment of thrombolytic disease

7-Oxabicyclopheptane substituted amino prostaglandin analogs useful in the treatment of thrombolytic disease

Arylhydroxamates useful as antiallergy agents

Aryl substituted 7-oxabicycloheptane compounds, useful in inhibiting platelet aggregation

7-Oxabicycloheptane substituted amino prostaglandin analogs and their use in inhibiting platelet aggregation and bronchoconstriction

7-oxabicycloheptane and 7-oxabicycloheptene compounds

7-Oxabicycloheptane and 7-oxabicycloheptene compounds

Prostacyclin intermediates

7-Oxabicycloheptane substituted prostaglandin interphenylene analogs useful in the treatment of thrombolytic disease

7-Oxabicycloheptane thio ethers useful as cardiovascular agents

7-Oxabicycloheptane substituted prostaglandin interphenylene analogs useful as cardiovascular agents

7-Oxabicyclo substituted prostaglandin phenyl carboxylic acid derivatives useful as cardiovascular agents

Method for preparing a prostacyclin intermediate

7-Oxabicycloheptane substituted amino prostaglandin analogs and their use in inhibiting platelet aggregation and bronchoconstriction

7-Oxabicycloheptane hydrazone prostaglandin analogs useful in treating thrombolytic diseases

Prostacyclin analogs and their use in inhibition of arachidonic acid-induced platelet aggregation and bronchoconstriction

Biphenyl hydroxamic acids

7-oxabicycloheptane substituted ox prostaglandin analogs

7-oxabicycloheptane-substituted oxa prostaglandin analogs and their use in the treatment of thrombolytic disease

7-oxabicycloheptane substituted oxa prostaglandin analgos useful in the treatment of thrombolytic disease

7-Oxabicycloheptane substituted oxa prostaglandin analogs and their anti-thrombotic compositions and methods

7-Oxabicycloheptane substituted thio prostaglandin analogs and their use in the treatment in thrombolytic disease

7-Oxabicycloheptane and 7-oxabicycloheptene compounds

7-Oxabicycloheptane substituted oxa prostaglandin analogs and their use in the treatment of thrombolytic disease

7-Oxabicycloheptane substituted prostaglandin alcohols and their use in the treatment of thrombolytic disease

Compositions of 7-oxabicycloheptane and 7-oxabicycloheptene compounds and a method for their use in inhibiting bronchoconstriction

7-Oxabicycloheptane substituted prostaglandin analogs useful in the treatment of thrombolytic disease

7-Oxabicycloheptane substituted oxa prostaglandin analogs and their use in the treatment of thrombolytic disease

7-Oxabicycloheptane substituted thiocarbamate prostaglandin analogs useful as cardiovascular agents

7-Oxabicycloheptane substituted thio prostaglandin analogs useful in treating platelet aggregation and bronchoconstriction

7-Oxabicycloheptane substituted carbamate prostaglandin analogs useful in treating platelet aggregation and bronchoconstriction

Method of use of bicycloheptane substituted prostaglandin analogs as cardiovascular agents

Phenyl hydroxamic acids including a hetero-containing substituent

Intermediates and method for producing intermediates useful in the preparation of 7-oxabicycloheptane prostaglandin derivatives

7-Oxabicycloheptane ethers useful in the treatment of thrombolytic disease

7-Oxabicycloheptane prostaglandin intermediates and method for preparing same

Dioxatricyclic prostacyclin analogs

Method for preparing 10,10-difluoro prostacyclins

Method for preparing 10,10-difluoro prostacyclin intermediates and new compounds produced thereby

Hydroxamic acid derivatives and method of using same

Dioxatricyclic prostacyclin analogs

6,6-Difluoro-5-hydroxy-4-(3-oxoalk-1-enyl)hexahydro cyclopenta[b] furan-2-ols

SCHERING CORP

Mercapto-acylamino acid antihypertensives

Acylamino acid antihypertensives in the treatment of congestive heart failure

Mercapto-acylamino acid antihypertensives

Mercapto-acylamino acid antihypertensives

Use of neutral metalloendopeptidase inhibitors in the treatment of hypertension

Carboxyalkylcarbonyl aminoacid endopeptidase inhibitors

Orally active antiandrogens